Membrane-type 1 matrix metalloproteinase-mediated progelatinase A activation in non-tumorigenic and tumorigenic human keratinocytes

被引:0
|
作者
P Baumann
P Zigrino
C Mauch
D Breitkreutz
R Nischt
机构
[1] University of Cologne,Department of Dermatology
[2] German Cancer Research Center,Division of Carcinogenesis and Differentiation
来源
British Journal of Cancer | 2000年 / 83卷
关键词
type IV collagenases; activation; keratinocytes; HaCaT-; cell–matrix interactions;
D O I
暂无
中图分类号
学科分类号
摘要
Elevated expression of type IV collagenases (MMP-2 and MMP-9) has been strongly correlated with tumour progression and metastasis in various tumours. Here, we analysed expression and activation of these MMPs in non-tumourigenic HaCaT cells and the malignant HaCaT variant II-4rt. In monolayer cultures, both cell types secreted latent MMP-2 (proMMP-2) in comparable amounts, while MMP-9 production was clearly higher in II-4rtcells. Upon contact with fibrillar collagen type I the malignant II-4rtcells, but not the HaCaT cells, gained the capability to activate proMMP-2. This process is shown to be membrane-associated and mediated by MT1-MMP. Surprisingly, all membrane preparations from either HaCaT cells or II-4rtcells grown as monolayers, as well as within collagen gels, contained considerable amounts of active MT1-MMP. However, within collagen gels HaCaT cells showed significantly higher TIMP-2 levels compared to II-4rtcells. This indicates that TIMP-2 might play a central role for MT1-MMP-mediated gelatinolytic activity. Indeed, collagen type I-induced MT1-MMP-mediated proMMP-2 activation by II-4rtmembranes could be completely abolished by an excess of TIMP-2. In conclusion, our data suggest that MT1-MMP-mediated proMMP-2 activation might be associated with malignant progression of epidermal tumour cells. © 2000 Cancer Research Campaign
引用
收藏
页码:1387 / 1393
页数:6
相关论文
共 50 条
  • [1] Membrane-type 1 matrix metalloproteinase mediated progelatinase A activation in non-tumorigenic and tumorigenic human keratinocytes
    Baumann, P
    Zigrino, P
    Mauch, C
    Breitkreutz, D
    Nischt, R
    BRITISH JOURNAL OF CANCER, 2000, 83 (10) : 1387 - 1393
  • [2] Expression of membrane-type 1 matrix metalloproteinase and activation of progelatinase A in human osteoarthritic cartilage
    Imai, K
    Ohta, S
    Matsumoto, T
    Fujimoto, N
    Sato, H
    Seiki, M
    Okada, Y
    AMERICAN JOURNAL OF PATHOLOGY, 1997, 151 (01): : 245 - 256
  • [3] Cell type-specific involvement of furin in membrane type 1 matrix metalloproteinase-mediated progelatinase A activation
    Sato, T
    Kondo, T
    Seiki, M
    Ito, A
    INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC APPLICATIONS, 1999, 878 : 713 - 715
  • [4] Enhanced production and activation of progelatinase a mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas
    Nakamura, H
    Ueno, H
    Yamashita, K
    Shimada, T
    Yamamoto, E
    Noguchi, M
    Fujimoto, N
    Sato, H
    Seiki, M
    Okada, Y
    CANCER RESEARCH, 1999, 59 (02) : 467 - 473
  • [5] Membrane-type matrix metalloproteinase-mediated angiogenesis in a fibrin-collagen matrix
    Collen, A
    Hanemaaijer, R
    Lupu, F
    Quax, PHA
    van Lent, N
    Grimbergen, J
    Peters, E
    Koolwijk, P
    van Hinsbergh, VWM
    BLOOD, 2003, 101 (05) : 1810 - 1817
  • [6] Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human oral squamous cell carcinomas: Implications for lymph node metastasis
    Shimada, T
    Nakamura, H
    Yamashita, K
    Kawata, R
    Murakami, Y
    Fujimoto, N
    Sato, H
    Seiki, M
    Okada, Y
    CLINICAL & EXPERIMENTAL METASTASIS, 2000, 18 (02) : 179 - 188
  • [7] Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human oral squamous cell carcinomas: Implications for lymph node metastasis
    Taketoshi Shimada
    Hiroyuki Nakamura
    Kaname Yamashita
    Ryo Kawata
    Yasushi Murakami
    Noboru Fujimoto
    Hiroshi Sato
    Motoharu Seiki
    Yasunori Okada
    Clinical & Experimental Metastasis, 2000, 18 : 179 - 188
  • [8] Membrane-type 1 matrix metalloproteinase-mediated pro-invasive properties of neuroblastoma initiating cells
    Nyalendo, Carine
    Hadj-Mimoune, Sarah
    Cournoyer, Sonia
    Beaunoyer, Mona
    Benoit, Alexandre
    Addioui, Anissa
    Teira, Pierre
    Haddad, Elie
    Momparler, Richard L.
    Sartelet, Herve
    CANCER RESEARCH, 2011, 71
  • [9] TIMP-2 promotes activation of progelatinase a by membrane-type 1 matrix metalloproteinase immobilized on agarose beads
    Kinoshita, T
    Sato, H
    Akiko
    Okada
    Ohuchi, E
    Imai, K
    Okada, Y
    Seiki, M
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (26) : 16098 - 16103
  • [10] Membrane-type matrix metalloproteinase-mediated activation of MMP-2 in the hematopoietic environment of AML, CML and MDS.
    Shirvaikar, N
    Marquez, LA
    Zhao, D
    Gan, K
    Turner, AR
    Larratt, L
    Janowska-Wieczorek, A
    BLOOD, 2003, 102 (11) : 242B - 242B